Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isatidis root dispersible tablets are a traditional Chinese medicine (TCM) formulation developed and manufactured by Jiangsu Pengyao Pharmaceutical. The active ingredient is derived from the dried root of *Isatis indigotica* Fort. (Radix Isatidis), which is widely used in East Asian medicine for its heat-clearing and detoxifying properties. The dispersible tablet formulation is designed to disintegrate rapidly in water, providing a convenient oral delivery method for patients. It is primarily indicated for the treatment of viral infections and inflammatory conditions, including the common cold, influenza, mumps, and sore throat. Pharmacologically, isatidis root contains a variety of bioactive compounds such as indirubin, indigo, and various polysaccharides that contribute to its broad-spectrum antiviral and anti-inflammatory activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isatidis root.